Choudhary R,
Reddy SS, Nagaraju R, Nagi R, Rathore P, Sen R. Effectiveness of
pharmacological interventions for Sjogren syndrome - A systematic review. J
Clin Exp Dent. 2023;15(1):e51-63.
doi:10.4317/jced.59891
https://doi.org/10.4317/jced.59891
___________
References
|
1.
Aframian DJ, Konttinen YT, Carrozzo M, Tzioufas AG. Urban legends series:
Sjögren's syndrome. Oral Dis. 2013;19:46-58 |
|
|
|
|
|
2.
Baldini C, Talarico R, Tzioufas AG, Bombardieri S. Classification criteria
for Sjogren's syndrome: A critical review. J Autoimmun. 2012;19:9-14. |
|
|
|
|
|
3.
Patel R, Shahane A. The epidemiology of Sjögren's syndrome. Clin Epidemiol.
2014;6:247-55. |
|
|
|
|
|
4.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons
SE, et al. Classification criteria for Sjogren's syndrome: a revised version
for the European criteria proposed by the American-European Consensus Group.
ARD. 2002;61:554-8. |
|
|
|
|
|
5.
Means C, Aldape MA, King E . Pediatric primary Sjögren syndrome presenting
with bilateral ranulas: a case report and systematic review of the
literature. International Journal of Pediatric Otorhinolaryngology. 2017;101:11-19. |
|
|
|
|
|
6.
Cifuentes Mutinelli M, Del Barrio Díaz P, Vera Kellet CA. Pilocarpine and
artificial saliva for the treatment of xerostomia and xerophthalmia in
Sjögren syndrome: a double-blind randomized controlled trial. 2018;179:1056-1061. |
|
|
|
|
|
7.
Papas AS, Sherrer YS, Charney M, Golden HE, Medsger Jr TA, Walsh BT, et al. Successful
treatment of dry mouth and dry eye symptoms in Sjögren's syndrome patients
with oral pilocarpine: a randomized, placebo-controlled, dose-adjustment
study. J Clin Rheumatol. 2004;10:169-77. |
|
|
|
|
|
8.
Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, et al.
Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome:
a randomized trial. Arch Intern Med. 2002;162:1293-300. |
|
|
|
|
|
9.
Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P. A double-blind,
randomized, placebo-controlled study of cevimeline in Sjögren's syndrome
patients with xerostomia and keratoconjunctivitis sicca. Arthritis & Rheumatism.
2002;46:748-754. |
|
|
|
|
|
10.
Kweon SM, Koh JH, Lee HN, Kim E, So MW, Shin HJ, et al. Primary Sjogren
syndrome diagnosed simultaneously with localized amyloidosis of the lacrimal
gland: A case report. Medicine (Baltimore). 2018;97:e11014. |
|
|
|
|
|
11.
Houghton K, Malleson P, Cabral D, Petty R, Tucker L. Primary Sjögren's
syndrome in children and adolescents: are proposed diagnostic criteria
applicable? The Journal of rheumatology. 2005;32:2225-2232. PMid:16265707 |
|
|
|
|
|
12.
Christensen LB, Petersen PE, Thorn JJ, Schiødt M. Dental caries and dental
health behavior of patients with primary Sjögren syndrome. Acta Odontologica
Scandinavica. 2001;59:16-120. |
|
|
|
|
|
13.
Touma Z, Sayad J, Arayssi T. Successful treatment of Sjogren's syndrome with
rituximab. Scandinavian journal of rheumatology. 2006;35:323-325. |
|
|
|
|
|
14.
de Mendonça Invernici M, Finger Stadler A, Vale Nicolau G, Naval Machado MÂ,
Soares de Lima AA, Compagnoni Martins M. Management of Sjogren's syndrome
patient: a case report of prosthetic rehabilitation with 6-year follow-up. Case
Rep Dent. 2014;2014:761251. |
|
|
|
|
|
15.
Means C, Aldape MA, King E. Pediatric primary Sjögren syndrome presenting
with bilateral ranulas: a case report and systematic review of the
literature. International Journal of Pediatric Otorhinolaryngology. 2017;101:11-19. |
|
|
|
|
|
16.
Flaitz CM. Parotitis as the initial sign of juvenile Sjogren's syndrome.
Pediatric dentistry. 2001;23:140-142. PMid:11340726 |
|
|
|
|
|
17.
Cummins MJ, Papas A, Kammer GM, Fox PC. Treatment of primary sjögren's syndrome
with low-dose human interferon alfa administered by the oromucosal route:
Combined phase III results. Arthritis Care & Research: Official Journal
of the American College of Rheumatology. 2003;49:585-593. |
|
|
|
|
|
18.
Hartkamp A, Geenen R, Godaert GL, Bootsma H, Kruize AA, Bijlsma JW, et al.
Effect of dehydroepiandrosterone administration on fatigue, well-being, and
functioning in women with primary Sjögren syndrome: a randomised controlled
trial. Annals of the rheumatic diseases. 2008;67:91-97. |
|
|
|
|
|
19.
Hosoda C, Hosaka Y, Ryu K, Kinoshita A, Saito K, Kuwano K. Pleuritis associated with primary
Sjogren syndrome. Respirology Case Reports. 2008;6:e00285. |
|
|
|
|
|
20.
Marino A, Romano M, Giani T, Gaggiano C, Costi S, Singh R, et al. Childhood
Sjogren's syndrome: An Italian case series and a literature review-based
cohort. In Seminars in Arthritis and Rheumatism. 2021;51:903-910. https://doi.org/10.1016/j.semarthrit.2020.11.004 |
|
|
|
|
|
21.
Edelstein R, Kilipiris GE, Machalekova K, Mouzalini E, Slobodianuk A, Javorka
V. Accuracy of minor salivary gland biopsy in the diagnosis of Sjögren
syndrome. Bratislavske Lekarske Listy. 2021;122:454-460. |
|
|
|
|
|
22.
Colaci M, Cassone G, Manfredi A, Sebastiani M, Giuggioli D, Ferri C.
Neurologic complications associated with Sjögren's disease: case reports and
modern pathogenic dilemma. Case Reports in Neurological Medicine. 2014;2014:590292. |
|
|
|
|
|
23.
Khurshudian AV. A pilot study to test the efficacy of oral administration of
interferon-α lozenges to patients with Sjögren's syndrome. Oral Surgery, Oral
Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2003;95:38-44. |
|
|
|
|
|
24.
Devauchelle-Pensec V, Mariette X, Jousse-Joulin S., Berthelot JM, Perdriger
A, Puéchal X, et al. Treatment of primary Sjögren syndrome with rituximab: a
randomized trial. Annals of internal medicine. 2014;160:233-242. |
|
|
|
|
|
25.
Gottenberg JE, Ravaud P, Puéchal X, Le Guern V, Sibilia J, Goeb V, et al.
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren
syndrome: the JOQUER randomized clinical trial. Jama. 2014;312:249-258. |
|
|
|
|
|
26.
Johansson G, Andersson G, Edwardsson S, Björn AL, Manthorpe R, Attström R.
Effects of mouthrinses with linseed extract Salinum® without/with
chlorhexidine on oral conditions in patients with Sjögren's syndrome. A
double-blind crossover investigation. Gerodontology. 2001;18:87-94. |
|
|
|
|
|
27.
Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, et al. Inefficacy
of infliximab in primary Sjögren's syndrome: results of the randomized,
controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
Arthritis & Rheumatism: Official Journal of the American College of
Rheumatology. 2004;50:1270-1276. |
|
|
|
|
|
28.
Meijer JM, Meiners PM, Vissink A, Spijkervet FKL, Abdulahad W, Kamminga N, et
al. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a
randomized, double-blind, placebo-controlled trial. Arthritis &
Rheumatism. 2010;62:960-968. |
|